GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dongkoo Bio&Pharma Co Ltd (XKRX:006620) » Definitions » Beta

Dongkoo Bio&Pharma Co (XKRX:006620) Beta : 0.90 (As of Mar. 04, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Dongkoo Bio&Pharma Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2025-03-04), Dongkoo Bio&Pharma Co's Beta is 0.90.


Dongkoo Bio&Pharma Co Beta Historical Data

The historical data trend for Dongkoo Bio&Pharma Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dongkoo Bio&Pharma Co Beta Chart

Dongkoo Bio&Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only - - 1.06 1.03 1.05

Dongkoo Bio&Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.05 0.98 0.99 1.03

Competitive Comparison of Dongkoo Bio&Pharma Co's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Dongkoo Bio&Pharma Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dongkoo Bio&Pharma Co's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dongkoo Bio&Pharma Co's Beta distribution charts can be found below:

* The bar in red indicates where Dongkoo Bio&Pharma Co's Beta falls into.



Dongkoo Bio&Pharma Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Dongkoo Bio&Pharma Co  (XKRX:006620) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Dongkoo Bio&Pharma Co Beta Related Terms

Thank you for viewing the detailed overview of Dongkoo Bio&Pharma Co's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Dongkoo Bio&Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
B-14F, M State Building, 114, Beobwonro, Songpagu, Seoul, KOR, 05836
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

Dongkoo Bio&Pharma Co Headlines

No Headlines